Member Info for dactions

We're being too downbeat in this thread - the opportunity now for us as shareholders is considerably enhanced than it was as recently as last year. Our market potential has changed with the CE marking now official and authorisation to sell this OTC.

China/Far east licensing in place with 50% royalties - fully funded to meet the relative modest cost for the FDA trial and cash in the bank to start production if needed. I think we can expect licensing news, rather than production plans in the near future, which will boost the sp significantly. As a LTH mysekf, paying years ago for some of my shares at 60p as well as the lower placing at 7p, nevertheless I'm looking for a return sometime this year upwards of £2. Depending on the pace of news, it's regularity and significance, will influence my judgement as to whether to stay even longer and reap yet higher returns.

The principal elements are now all here - the future looks very promising.

I agree with most of the comments here so far - it has been an uncomfortable ride at times but the evidence is becoming ever more certain that success is possible/likely - we are though at the mercy of short-term traders which I suspect frightens some otherwise longer term holders selling off their shares when they see the sp gyrates.

As a holder of SNG, pre-AstraZenica days - the sp has been all over the place in those long years.

Strictlyinc - AIM trading can be fortuitous if you time it right - so well done. With a fair wind now, and even just snippets of news, we at least have every chance of seeing the sp back to at least £2 plus.

Syn00Gold - ignore dgdg1 - I doubt he's really interested judging by his comments on another BB (FUM).

A good day - GLA

Totally agree Fruitsnveg - they've shown in vitro that SNG001 works against two variants Kent and South African which is something we hadn't known before - this is the message that the news channels need to appreciate.

And with the current concerns regarding the Indian variant, I would like to think today's RNS will help push our own NHS towards a rethink on therapeutics such as SNG001.

There's too much negativity on this board - today's RNS is all about our BoD pushing where it can support of the sp. Yes, we wish they'd gone faster at last year end, but we are where we are and today's confirmation of SNG001 effectiveness will, I am sure, start us on an upward track again.

Bought more shares at market opening - paid £1.11
GLA

There's too much negativity on this board - today's RNS is all about our BoD pushing where it can support of the sp. Yes, we wish they'd gone faster at last year end but we are where we are and today's confirmation of SNG001 effectiveness will, I am sure, start us on an upward track again.

TruroTrader - just as I posted on another thread earlier - I realised that today's announcement now made it two QCs appointed. Andi agree with you that it's stated elsewhere on the internet, that they need to appoint an Arbitration Panelist - perhaps one of the QCs will act the part.

I hope they can get a move on now with this process. It must be dominating Chris Gilbert's thinking when he'll be better used in promoting new contracts/sales.

unvrkw - they're still alive

Today's news is at least evidence of that - reading your last message in April:
"Everything seems to sit now on a court case which could be weeks, months or years away, no change of investment from me but boy is this slow going."

Everything re. Fox, I agree is painfully slow - and with the announcement today of the appointment of a Queen's Counsel we move a little closer to a resolvement. I still feel that the fact it has gone to Arbitration, a good middle path solution will be found and which will be beneficial to us as shareholders.

Geovanni - this is old news and besides I recall it relates to their trial of Interferon Beta 1-b whereas SNG is type 1-a

https://pubmed.ncbi.nlm.nih.gov/33189161/

MrBassee - I can sympathise with you as it's been a nice journey from not much more than 2p just a few months ago and was close to a shot at 8p. But we all know stocks don't go up in a straight line and sometimes it's even more frustrating if you just bought in at a higher price.

Rob_ comments are bang on though as the funds will go to expand the business not dilute your shareholding and the Institutional Investors recognise that, which is why the placing was so easily taken up. The Carbon Credits business is still a newish industry and Woodbois are in a good position to exploit that. But I've said this before several times, if Lumber was called instead Gold, everybody would be talking about the way the market prices have mushroomed and Woodbois is getting its share of the increases. It won't be long before we learn of first half results - WBI has been quick to report these past months. I'm as good as certain that the figures will be good and it would be really disappointing if the sp didn't reflect the good news.

Hang in there MrBasse.

The.Italian - I’d forgotten LO’s potential buy in price is also 40p and perhaps on reflection £10 millions isn’t so big to see much change in shareholding percentages.

DosandDonts - you may well be right about a soon to be announced commercial deal - after all the Chinese deal was a surprise !!

Hope so - GLA

I agree Bucolic - I had to look the word up !

Glad you were able to bid for shares - by the time I was home from work 7.30pm, the offer had closed. I was indecisive though as only recently bought two large share top-ups circa 50p so at least can now blame PrimaryBid. But this over-subscription does auger well for the sp, even if not immediately. I'll be interested to see if Lombard Odier has increased its stake and any other II names that appear with larger holdings.

With CE marking, the recent Chinese deal, the cover for the funding of the small FDA trial plus money in the bank for production costs does put FUM in a completely different risk category now. GLA

Stevekeegan - I've used Primary Bid a number of times and this is the first time I've been locked out of any offer so on my limited evidence, I agree with your thinking and I too take that as a positive sign.

I've only just seen the news (as working) - I'm surprised that retail offer on Primary Bid is already closed at 19:30 ?

Thanks Sandy - good find.
One can go straight to that part of the discussion with Dr. Mario Castro around 35 mins in.

Thanks fatfatwil - I do agree about the potential mid to long term. But I'm hoping too for good half year results which will give short-term lift to the sp too.

Many of us on this BB have seen a good rise in the sp since the new management came on board and also the thrust of the business changed to exclusively timber management mostly concentrated in Gabon - a relatively stable African country.

Last July the placing in the midst of the Pandemic was done at 2p and you'd have needed to know the Company's background to have felt confident to buy into it - I did then and substantially lowered my buying average. Just take a look at the share graph and you can see for yourself the steady progress to around 7p in a relatively short time.

The new BoD have kept shareholders regularly informed of their trading progress and have committed to paying dividends after 2021 results are known. They asked for £5 millions to meet new equipment and new concessions and got £6 millions. I was allocated all that I asked for in yesterday's Primary Bid offer and as it stands right now, it seems to me there's an excellent opportunity to buy in at close to the offer price.

World lumber markets are on the up right now - if it were called Gold rather than lumber, everyone would be talking about it. Lumber is still under the radar as far as I can see. And then there is Carbon Offset markets - and Woodbois is buying up, with much of the placing funds, plain savanna lands and concessions for new plantings. This market alone could be very exciting for Woodbois.

I'm very optimistic that we'll see excellent share growth this year and well worth considering for anyone new to Woodbois .

Good luck all.

Thanks Steffy for adding this to our BB - it's always nice when a respected financial journalist picks out a stock which echoes what I've been thinking and saying these past 12 months.

Go to approx 22mins + for talk about Woodbois.

What a lot of nonsense this particular BB has been showing these past few weeks - what with LB continuing ad nauseam and now jackbogle warning us - hedgefundking having constant conversations with him - far2l8 etc etc.

Curious isn't it ?
They've all turned up since the good news of Futura has come about. And it is good news too - a fully funded Asian markets deal that will see FUM receiving 50% royalties, a CE marking allowing marketing in European and UK and many other countries. Good spread of Institutional investors, holding.

Further good news is just round the corner - so, ignore them all and Filter any of these newcomers - they have nothing worth reading - they're all 'Good Cop' - 'Bad Cop'. In the years I've been on LSE, I've never seen a BB like it.

Well put Yenom - you've summed up the derampers brilliantly.

Theo - quite agree with you.

I've been in this company a good few years now so did buy shares at very much higher prices than now eg 18p but increased holdings considerably at last year's 2p placing and also subsequently this year, when I recognised what the Board's change in emphasis to Gabon was making in their results.

The Directors are on life-changing money that they'll make on their options at this rate of progress - fortunately for us, the earliest they vest is August 2024. They made it quite clear at the July/August 2020 placing they will pay dividends:
"In turn the Company is aiming to start making returns to shareholders following the conclusion of the 2021 financial year through a sustainable dividend policy."

If the profits emerge as we all hope, then paying Dividends and growing them, will be the best way for the Directors to make their fortunes - and ours too of course !